28.2 C
Vientiane
Tuesday, July 8, 2025
spot_img
Home Blog Page 204

Rockwell Automation Launches EtherNet/IP In-cabinet Solution to Help Manufacturers Build Smarter, More Efficient Panels

New offering can cut wiring time by up to 80%, speeding production and innovation

MILWAUKEE, Wis., May 20, 2025 /PRNewswire/ — Rockwell Automation, Inc. (NYSE: ROK), the world’s largest company dedicated to industrial automation and digital transformation, today announced the release of its EtherNet/IP™ In-cabinet Solution, a major advancement designed to meet the growing demand for smarter, faster and more connected manufacturing operations.

Rockwell Automation launches EtherNet/IP In-cabinet Solution to help manufacturers build smarter, more efficient panels
Rockwell Automation launches EtherNet/IP In-cabinet Solution to help manufacturers build smarter, more efficient panels

As companies strive to improve productivity and reduce downtime, traditional hard-wired control panels often stand in the way, limiting data access and complicating system upgrades. The EtherNet/IP In-cabinet Solution addresses those challenges by streamlining communications between devices with the panel, making system integration simpler, boosting real-time data access and helping manufacturers make faster, more informed decisions.

“Our EtherNet/IP In-cabinet Solution is a game-changer in industrial connectivity,” said Kelly Passineau, product manager at Rockwell Automation. “By leveraging single-pair Ethernet/IP technology, we’re helping customers reduce installation time, enhance operational efficiency and integrate wired components into a more intelligent, data-driven network.”

Early adopters are already seeing the impact. Volga, a Rockwell Systems Integrator Partner and a leading manufacturer based in Brazil specializing in electrical, mechanical and automation control, reported dramatic improvements after adopting the EtherNet/IP In-Cabinet Solution.

“The EtherNet/IP In-cabinet Solution reduced our assembly time by over 65%, enabling us to wire starters and panel operators in just over an hour,” said Carlos Leopoldo, commercial director at Volga. “Beyond the significant time savings, this system provides numerous benefits for our panel builders, including space efficiency, customizable panel operator colors, a reduction in SKUs, minimized risk of incorrect connections and more straightforward inspections. It’s a well-designed solution that enhances efficiency and reliability for both panel builders and end users who can benefit from improved communication, diagnostics and easier maintenance.”

Key benefits of this new offering include:

  • Faster Installation: When implemented in accordance with recommended standards, it can help cut wiring time by up to 80% compared to traditional hard-wired installation.
  • Optimized Space: The compact design allows for efficient use of cabinet space, enabling more devices to be installed in the same footprint and reduces overall panel size.
  • Improved Data Access: Boost productivity with quick, real-time communication between devices.
  • Scalability: Easily expand and adapt to future networking needs without major infrastructure changes.

Additionally, a plug and play design enables easy configuration, commissioning and maintenance, ultimately reducing disruptions to production schedules.

Learn more about the EtherNet/IP In-cabinet Solution on Rockwell’s website.

About Rockwell Automation
Rockwell Automation, Inc. (NYSE: ROK) is a global leader in industrial automation and digital transformation. We connect the imaginations of people with the potential of technology to expand what is humanly possible, making the world more productive and more sustainable. Headquartered in Milwaukee, Wisconsin, Rockwell Automation employs approximately 27,000 problem solvers dedicated to our customers in more than 100 countries as of fiscal year end 2024. To learn more about how we are bringing the Connected Enterprise® to life across industrial enterprises, visit www.rockwellautomation.com.

 

AZI Regains Compliance with Nasdaq Minimum Bid Price Requirement

BEIJING, May 20, 2025 /PRNewswire/ — Autozi Internet Technology (Global) Ltd. (Nasdaq: AZI) (“Autozi” or the “Company”), an automotive products and services company in China, today announced that it has received a written notice (the “Compliance Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) dated May 16, 2025, informing the Company that it has regained compliance with the minimum bid price requirement set forth under the Listing Rule 5450(a)(1) (the “Minimum Bid Price Requirement”).

As previously announced, the Company was notified by Nasdaq on February 5, 2025 that the Company’s Class A ordinary shares failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days.

According to the Compliance Notice, the Company regained compliance with the Minimum Bid Price Requirement because the closing bid price of the Company’s Class A ordinary shares has been at $1.00 per share or greater for 14 consecutive business days, from April 28 through May 15, 2025, and the matter is now closed.

About Autozi

Autozi Internet Technology (Global) Ltd. is a leading, fast-growing provider of lifecycle automotive services in China. Founded in 2010, Autozi offers a comprehensive range of high-quality, affordable, and professional automotive products and services through both online and offline channels across the country. Leveraging its advanced online supply chain cloud platform and SaaS solutions, Autozi has built a dynamic ecosystem that connects key participants across the automotive industry. This interconnected network enables more efficient collaboration and streamlined processes throughout the entire supply chain, positioning Autozi as a key driver of innovation and growth in the automotive services sector.

Contact Information

The Blueshirt Group
Jack Wang
Email: Jack@blueshirtgroup.co 

Modern Dairy Wins Six Awards in Extel’s 2025 Asia (ex-Japan) Executive Team Rankings

HONG KONG, May 20, 2025 /PRNewswire/ — On May 20, the prestigious financial magazine “Extel” (formerly “Institutional Investor”) officially announced the results of the “2025 Asia (ex-Japan) Executive Team-SMID” rankings. The survey assessed and examined companies across multiple dimensions, covering governance of the board of directors, the quality of investor relations programs, environmental, social, and governance (ESG) practices, the leadership of CEOs and CFOs, and the performance of investor relations professionals. Modern Dairy (1117 HK) demonstrated outstanding performance in the competitive field, securing six prestigious awards in the consumer staples category, including: Best Company Board, Best IR Program, Best ESG, Best CEO (Mr. Sun Yugang), Best CFO (Mr. Zhu Xiaohui), and Best IR Professional (Ms. Lo Pik Fai, Ruby).

Award

Executive

Ranking

Corporate Awards

Best Company Board

Combined 2nd, Sell Side 2nd

Best IR Program

Sell Side 2nd, Combined 3rd

Best ESG

Combined 2nd, Sell Side 2nd

Individual Awards

Best CEO

Mr. Sun Yugang

Sell Side 2nd, Combined 3rd

Best CFO

Mr. Zhu Xiaohui

Sell Side 2nd, Combined 3rd

Best IR Professional

Ms. Lo Pik Fai, Ruby

Combined 3rd, Buy Side 3rd, Sell Side 3rd

The Extel survey is globally renowned for its rigorous evaluation criteria, objective and fair selection process, and highly professional assessment system, making it a highly anticipated and authoritative event in the international capital market. This year’s survey involved 5,437 buy-side portfolio managers and analysts from 1,167 institutions with an estimated $2 trillion in Asia equities, as well as 863 sell-side analysts from 157 brokerage firms, They nominated a total of 1,668 companies and 2,367 individuals across 18 sectors. The survey systematically presents the capital market’s professional judgment on listed companies through multi-dimensional independent assessments. The results provide global investment institutions with highly valuable research data, enjoying widespread credibility in investment decision-making and investor relations management, and are regarded as an industry benchmark.

Modern Dairy’s Investor Relations team is consistently dedicated to maintaining close communication with investors through various channels, including regular earnings releases, participation in reverse roadshows, hosting investor and analyst visits, and attending investment forums. The team proactively addresses market concerns, ensuring timely and transparent disclosure. Currently, over 10 brokerage firms have initiated research coverage of the company, all of which have issued positive investment ratings. This reflects market’s focus in Modern Dairy’s future development.

While focusing on improving the quality and efficiency of its core business, Modern Dairy prioritises the comprehensive integration and innovative practice of ESG principles. Guided by its sustainable development strategy “FRESH,” the company collaborates with global partners to build a green supply chain and actively leads the industry’s sustainable development efforts. Notably, MSCI, a leading global index company, released its latest rating report in May, upgrading Modern Dairy’s ESG rating from BBB to A, ranking it first in the Chinese animal husbandry industry. This achievement underscores the company’s outstanding performance in the field of sustainable development.

Modern Dairy is deeply honored to receive the trust and support from capital market professionals and authoritative institutions, viewing it as an affirmation of the effectiveness of its investor relations management efforts. Moving forward, the company will continue to improve its modern corporate governance system, actively promote the implementation of its ESG strategy, and further deepen its efficient interaction with the capital market.

Cannes Premiere: Lenovo Shines Spotlight on Chinese Wildlife Conservation Innovation with Lu Chuan’s Qinghai-Tibet Plateau Wildlife Park

CANNES, France, May 20, 2025 /PRNewswire/ — Lenovo Group and renowned Chinese film director Lu Chuan today premiered the documentary Qinghai-Tibet Plateau Wildlife Park at the 78th Cannes Film Festival. Highlighting China’s innovation in wildlife conservation, the documentary showcases the beauty of plateau wildlife and the unique approach to conservation rooted in traditional Eastern wisdom. Upon its debut, the film received unanimous acclaim at Cannes.

Lu Chuan at Cannes Wildlife & Cinema Seminar
Lu Chuan at Cannes Wildlife & Cinema Seminar

Alongside the screening, a seminar was held exploring the importance of wildlife documentaries in raising awareness for environmental issues. The seminar brought together environmental advocates, filmmakers, and technology specialists from around the world to engage in discussions about the film’s portrayal of China’s pioneering wildlife conservation practices at the Qinghai-Tibet Plateau Wildlife Park (QWP) known as the QWP Model.

Among the attendees was Greg Reitman, widely regarded as Hollywood’s “Green Filmmaker”, stating: “My filmmaking is fueled by a passion for spotlighting environmental issues and driving positive change. The film Qinghai-Tibet Plateau Wildlife Park has inspired me — AI serves as a bridge, enabling us to monitor wildlife non-invasively and guiding us toward a future of living in harmony with all beings through respect and protection.”

The QWP Model focuses on providing comprehensive care for injured wildlife, using technology to assess their potential for survival in the wild, and prioritizing their reintroduction to natural habitats. The distinct conservation philosophy stems from local beliefs in the cycle of reincarnation, where all spirits – humans, animals, and plants – can be reborn as another, making all life forms equal and deserving of the same respect and care.

By integrating cutting-edge AI into the park’s operations, Lenovo has built the first AI Park on the plateau, transforming how conservationists research, rescue, and rehabilitate wildlife on the plateau. Key applications include using AI to recognize indicative wildlife behaviors for advanced care, to collect and analyze real-time data for improved reintroduction strategies, and to automatically document medical records for long-term research.

More than a cinematic triumph, Qinghai-Tibet Plateau Wildlife Park’s Cannes debut shows how Chinese conservation philosophies, powered by Lenovo AI, offer a unique solution to global ecological challenges. As part of Lenovo’s commitment to ‘Smarter AI for All’, this collaboration strives to utilize AI to build a more sustainable coexistence between humans and nature.

MiTAC Computing Democratizes AI at COMPUTEX 2025

TAIPEI, May 20, 2025 /PRNewswire/ — At COMPUTEX 2025, MiTAC Computing Technology Corporation, a leading server platform designer and manufacturer and a subsidiary of MiTAC Holdings Corporation (TSE:3706), drives innovation in AI, High-Performance Computing (HPC), cloud, and enterprise data center solutions at COMPUTEX. MiTAC will showcase high-density AI and GPU servers featuring Broadcom PCIe switches, NICs and RAID adapters.

MiTAC Computing and Broadcom's Joint Innovation Showcase
MiTAC Computing and Broadcom’s Joint Innovation Showcase

“Broadcom’s high-performance NICs, PCIe switches, and RAID technologies have helped us deliver flexible server solutions that power next-generation computing,” said Rick Hwang, President of MiTAC Computing Technology Corp. “Our ongoing collaboration ensures that customers—from research institutes to mid-sized enterprises—can adopt AI and HPC more efficiently and cost-effectively.”

“Broadcom is pleased to support the MiTAC AI and HPC demonstrations at COMPUTEX with our broad portfolio of connectivity solutions,” said Jas Tremblay, vice president and general manager of the Data Center Solutions Group, Broadcom. “We understand the importance of democratizing AI by expanding access to accelerated computing across the industry and open ecosystem. MiTAC’s AI platforms are designed to provide the scalability, speed, and reliability needed to meet the demands of today’s advanced data-driven workloads.”

At the center of the COMPUTEX showcase are two platforms designed to meet the demands of modern AI and HPC:

  • MiTAC G8825Z5 – A high-density AI server built for large-scale training workloads, leveraging 4 Broadcom PEX89104 PCIe 5.0 switches, and a mix of 8 Broadcom P1400GD (E-W) and 4 P2200GD (N-S) high-speed NICs to deliver ultra-fast GPU communication and optimized AI throughput.
  • MiTAC G4520G6 – A powerful 4U GPU server tailored for HPC and AI tasks, featuring 2 Broadcom PEX89104 PCIe 5.0 switches and Broadcom RAID solutions to ensure performance, reliability, and seamless GPU scalability for compute- and data-intensive workloads.

MiTAC’s flexible system architectures, featuring Broadcom’s scalable interconnect and storage solutions will empower organizations of all sizes – from enterprise IT to research institutions – to deploy powerful AI and HPC systems without the high cost or complexity traditionally associated with them.

Visit MiTAC Computing at COMPUTEX 2025 – Booth M1110

Experience MiTAC Computing’s Broadcom-enabled product lineup and talk with solution experts.

Explore more: https://www.mitaccomputing.com/en/campaign/computex2025

About MiTAC Computing Technology Corporation

MiTAC Computing Technology Corp., a subsidiary of MiTAC Holdings, delivers comprehensive, energy-efficient server solutions backed by industry expertise dating back to the 1990s. Specializing in AI, HPC, cloud, and edge computing, MiTAC Computing employs rigorous methods to ensure uncompromising quality not just at the barebone level but more importantly, at the system and rack levels—where true performance and integration matter most. This commitment to quality at every level sets MiTAC Computing apart from others in the industry. The company provides tailored platforms for hyperscale data centers, HPC, and AI applications, guaranteeing optimal performance and scalability.

With a global presence and end-to-end capabilities—from R&D and manufacturing to global support—MiTAC Computing offers flexible, high-quality solutions designed to meet unique business needs. Leveraging the latest advancements in AI and liquid cooling, along with the recent integration of Intel DSG and TYAN server products, MiTAC Computing stands out for its innovation, efficiency, and reliability, empowering businesses to tackle future challenges.

Visit our corporate website: https://www.mitaccomputing.com/

Storage Meets AI at COMPUTEX 2025: Lexar Introduces Innovative Product Lines

TAIPEI, May 20, 2025 /PRNewswire/ — Lexar, a leading global brand in storage solutions, is showcasing its innovations at Computex 2025, held from May 20 to 23 at the Taipei Nangang Exhibition Center. Under the theme “Storage Meets AI,” Lexar is featured alongside Longsys Group at booth J1 211a, 1F, Hall 1.

As AI becomes more integrated into everyday life, users are increasingly focused on the capabilities of storage products. Lexar’s offerings are renowned for their large capacity, high-speed performance, and dependable quality, effectively catering to the needs of PC enthusiasts, gamers, and professional creators.

Deeply Engaged with Gamers

Lexar showcased a series of products specifically designed for gamers. The Lexar ARES RGB 2nd Gen DDR5 Desktop Memory, featuring premium SK Hynix DRAM chips, offers high speeds of up to 8000MT/s, and 6000MT/s with a timing of CL26. Lexar Ares series teamed up with AMD and Gigabyte’s high-end product series to form a high-performance PC hardware combination – ‘AAA’ gear for AAA gaming.

Lexar’s ARES RGB 2nd Gen DDR5 memory modules—specifically the 16GB (7200 MT/s) and 24GB (8000 MT/s) versions—are compatible with Intel’s 200S Boost initiative, which maximizes processor performance. These modules comply with the Overclocking Profile standard, ensuring high quality and reliability.

For internal SSDs, Lexar showcased two next-generation SSDs: the Lexar Professional NM990 PCIe Gen5.0 NVMe M.2 2280 SSD and the Lexar Professional NM1090 PRO PCIe Gen5.0 NVMe M.2 2280 SSD. Both can provide exceptional performance of up to 14GB/s read speed and are perfect for gaming and professional rendering.

In addition, Lexar also showcased the recently released PLAY PRO microSD Express memory card, which is ideal for the latest handheld gaming console.

More for Professional Creators

For professional creators, Lexar continuously offers innovative products to meet their demands. Among these is the new Lexar NFC Encryption Portable SSD. This SSD utilizes Lexar’s self-developed control chip and features NFC technology that requires unlocking for recognition, optimizing power dissipation and enhancing transmission stability while comprehensively protecting user privacy.

Lexar also showcased the Go Portable SSD with Hub, which enables content creators to shoot seamless video directly from their mobile phones. It successfully garnered over $1 million in user pledges on Kickstarter and raised nearly 12 million TWD on Zeczec, a crowdfunding platform in Taiwan.

Completing its offerings for photography enthusiasts, Lexar presents pexar digital picture frames. Available in both 15.6″ and 11″ sizes, these frames allow users to upload and showcase their favorite photos and videos from afar. They feature anti-glare touch screens for enhanced viewing and effortless setup. Each frame includes 32GB of built-in Lexar storage, capable of holding up to 40,000 photos, with the option to expand storage via a USB flash drive or SD card. Additionally, the 11″ frame boasts a stunning 2K resolution display.

Media kit

Press images: https://www-oss.lexar.com/lexar/files/PR/COMPUTEX2025_press_images.zip 

About Lexar

For more than 29 years, Lexar has been trusted as a leading global brand of memory solutions. Our award-winning lineup includes memory cards, USB Flash Drives, card readers, solid-state drives, and DRAM. With so many options, it’s easy to find the right Lexar solution to fit your needs. For more information, please visit lexar.com and follow us on Instagram, Facebook and LinkedIn.

BioFlag Showcases Innovative Probiotic Solutions at Vitafoods Europe 2025

BARCELONA, Spain, May 20, 2025 /PRNewswire/ — BIOFLAG CO.,LTD.(Bioflag), a leading probiotic enterprise located in China, proudly unveiled its scientifically validated functional probiotic solutions at Vitafoods Europe 2025, drawing high attention from global media.

At the event, BioFlag highlighted its cutting-edge products, including clinically-proven probiotic strains and finished probiotic products targeting gut health, immune regulation, metabolic health, weight management, oral care, and emotional well-being. The company also introduced customized probiotic solutions tailored to meet stringent European and American standards.

Key innovations include:

Bifidobacterium animalis subsp. lactis BL-99, sourced from their Chinese maternal-infant probiotic strain library. BL-99 holds 12 Chinese invention patents covering gut health, immune regulation, and bone health, and is widely used in infant formula, yogurt, and dietary supplements.

Lactobacillus paracasei K56, isolated from the gut of healthy Chinese infants and clinically proven to reduce body fat, visceral fat, and waist circumference[1]. This strain has received 9 Chinese invention patents and is supported by 12 published research studies.

Bifidobacterium animalis subsp. lactis CP-9, derived from the breast milk of healthy Chinese mothers, patented in China for anti-obesity effects and the treatment or prevention of jaundice.

As a representative of China’s probiotics industry, BIOFLAG CO.,LTD. has demonstrated its its full industrial chain capabilities:

  • A proprietary library of over 3,500 strains and 30+ functional screening platforms
  • More than 130 patents granted and 100+ scientific papers published
  • International certifications including GMP, FSSC22000 and HALAL
  • Production capacity spanning powders, tablets, capsules, and other dosage forms

During the exhibition, BIOFLAG CO.,LTD. reached cooperation intentions with dozens of enterprises and institutions from Europe, North America and other places. A company spokesperson stated, “Drawing on nearly two decades of expertise in functional probiotics, we remain committed to driving innovation in R&D and intelligent manufacturing to deliver superior health solutions to our global customers.”

For more information, visit: https://en.bioflag.com/

[1] Kadeer G, Fu W, He Y,  et al. Effect of different doses of Lacticaseibacillus paracasei K56 on body fat and metabolic parameters in adult individuals with obesity: a pilot study[J]. Nutr Metab. 2023, 20(1): 16.

Ascletis Announces First Participants Dosed in a U.S. Clinical Study Combining Adipose-Targeted, Once-Monthly Injectable Small Molecule THRβ Agonist, ASC47, and Semaglutide for the Treatment of Obesity

The combination study is designed to evaluate the safety and preliminary efficacy of a single-dose of ultra-long-acting subcutaneously administered ASC47 in combination with four doses of semaglutide (0.5 mg, once-weekly) in participants with obesity.

Asan adipose-targeted, muscle-preserving weight loss drug candidate for the treatment of obesity, ASC47 monotherapy demonstrated a half-life of up to 40 days in a Phase Ib study in participants with obesity.

In a head-to-head diet-induced obese (DIO) mouse model, low dose ASC47 in combination with semaglutide demonstrated a 56.7% greater reduction in body weight with muscle preservation compared to semaglutide monotherapy.

Topline data from the combination clinical study are expected in the fourth quarter of 2025.

HONG KONG, May 20, 2025 /PRNewswire/ — Ascletis Pharma Inc. (HKEX:1672, “Ascletis”) announces that the first participants have been dosed in the randomized, double-blind, placebo-controlled study (ASC47-103 study) evaluating the safety and preliminary efficacy of single-dose, ultra-long-acting subcutaneously (SQ) administered ASC47 in combination with semaglutide in participants with obesity who do not have Type 2 diabetes. The ASC47-103 study, conducted in the U.S., consists of three cohorts with single ascending doses (10 mg, 30 mg and 60 mg) of ASC47 or volume-matched placebo. Participants in each cohort will also receive four doses of semaglutide (0.5 mg, once weekly) (NCT06972992).

ASC47 is an adipose-targeted, ultra-long-acting SQ injected thyroid hormone receptor beta (THRβ) selective small molecule agonist, discovered and developed in-house at Ascletis. ASC47 possesses unique and differentiated properties to enable adipose targeting, resulting in dose-dependent high drug concentrations in the adipose tissue. ASC47 monotherapy demonstrated a half-life of up to 40 days in a Phase Ib study in participants with obesity. In a head-to-head diet-induced obese (DIO) mouse model, low dose ASC47 in combination with semaglutide demonstrated a 56.7% greater reduction in body weight with muscle preservation compared to semaglutide monotherapy.

Topline data from the ASC47-103 study are expected in the fourth quarter of 2025.

“To our knowledge, this is the first clinical study combining THRβ targeting mechanism and an incretin drug for obesity,” said Jinzi Jason Wu, Ph.D., Founder, Chairman and CEO of Ascletis, “We believe data from this combination study will help us design our once-monthly combination study of ASC47 and ASC30 (GLP-1R agonist), both of which have demonstrated a long half-life of 40 days and 36 days, respectively, in participants with obesity.”

About ASC47-103 Study

The ASC47-103 study, conducted in the U.S., is a randomized, double-blind, placebo-controlled clinical study designed to evaluate the safety and preliminary efficacy of single-dose, ultra-long-acting subcutaneously (SQ) administered ASC47 in combination with semaglutide in participants with obesity (body mass index ≥ 30 kg/m2).  The ASC47-103 study consists of three cohorts: Cohort 1 participants will receive a single dose of 10 mg ASC47, or volume-matched placebo via SQ injection, and four doses of semaglutide (0.5 mg, once-weekly) via SQ injection. Cohort 2 participants will receive a single dose of 30 mg ASC47, or volume-matched placebo via SQ injection, and four doses of semaglutide (0.5 mg, once-weekly) via SQ injection. Cohort 3 participants will receive a single dose of 60 mg ASC47, or volume-matched placebo via SQ injection, and four doses of semaglutide (0.5 mg, once-weekly) via SQ injection.

About Ascletis Pharma Inc.

Ascletis is an innovative R&D driven biotech listed on the Hong Kong Stock Exchange (1672.HK), covering the entire value chain from discovery and development to GMP manufacturing. Led by a management team with deep expertise and a proven track record, Ascletis is focused on metabolic diseases by addressing unmet medical needs from a global perspective. Ascletis has multiple clinical stage drug candidates in its metabolic disease pipeline.

For more information, please visit www.ascletis.com.

Contact:

Peter Vozzo
ICR Healthcare
443-231-0505 (U.S.)
Peter.vozzo@icrhealthcare.com

Ascletis Pharma Inc. PR and IR teams
+86-181-0650-9129 (China)
pr@ascletis.com
ir@ascletis.com